The Compensation Scheme
for Radiation-Linked Diseases (CSRLD) is a joint initiative between
the UK’s nuclear-sector employers and their trade unions.
The Scheme is designed to provide an alternative to legal action
for past and present employees of participating employers who have
been exposed to radiation during their work and who are subsequently
diagnosed to be suffering from cancer or cataracts. It has had a
successful year and is continuing to process cases.
The scheme has been in existence since 1982 and the participating
employers have expanded since its inception to include: Sellafield
Ltd, Springfields Fuels Ltd, United Kingdom Atomic Energy Authority,
Dounreay Site Restoration Ltd, Research Sites Restoration Ltd, URENCO
UK Ltd, EDF Energy Nuclear Generation Ltd, Magnox Ltd, the Ministry
of Defence, AWE plc, Babcock Marine
(Devonport Royal Dockyard) Ltd, Babcock Marine (Rosyth Royal Dockyard)
Ltd, Babcock Marine (Clyde) Ltd, GE Healthcare Ltd, Low Level Waste
Repository (Drigg) and other related Specified
The nuclear-sector employers and the Nuclear Decommissioning Authority are fully supportive of the Compensation Scheme which provides nearly complete coverage of the UK nuclear industry employees. Specified Companies.
The participating trade unions and staff associations are the Civil
Nuclear Police Federation, the FDA, GMB Union, Prospect (incl Public
and Commerical Services Union), UNITE (incl Union of Construction,
Allied Trades and Technicians), UNISON and the Defence Police Federation.
Cases which can be considered under the scheme are assessed by
the application of technical criteria jointly agreed between management
and trade unions. The applied criteria are more generous to the
claimant than those likely to be used for a legal action. The CSRLD
contains further generosity in that it awards payments for cases
with a causation probability of 20% or above. In a court case a
claimant must prove a causation probability of 50% where an ‘all
or nothing’ approach based on the balance of probabilities
In line with a commitment to ensure that the scheme reflects the
latest scientific and technical knowledge, new schedules were implemented
in 2009 based on the findings of the BEIR Vll and UNSCEAR reports
of 2006. (Changes in science can result in increases or decreases
in causation probability).) The Compensation Scheme carried out
a review of all previous cancer cases using the new technical basis
to arrive at an understanding of causation probability for those
cases capable of being caused (or influenced) by radiation. (This
review is referred to as a retrospection exercise) It then secured
agreement from the funding bodies for the duty holder organisations
to undertake, as appropriate, financial settlement proceedings.
These proceedings remain underway. However this revised technical
basis did not include cataracts. In 2011 the International Commission
for Radiological Protection (ICRP) issued a statement on tissue
reactions that recommended a reduction in the absorbed dose threshold
for the induction of cataracts. To reflect the changes in the ICRP
recommendations a revised cataract schedule was produced by the
scheme and implemented in 2012. Following approval from the relevant
duty holder organisations, a cataract retrospection exercise has
been undertaken and successful cases identified. Agreement from
the funding bodies has been obtained and steps have been initiated
to progress these claims to financial settlement proceedings.
Following on from a Scheme review and Technical revisions, Council
agreement was reached in 2015 on the implementation of - revised
Scheme Governance arrangements and protocols in support of case
The Scheme received 49 new claims during the 2016/17 financial
year and 2 compensation settlements reached completion.
There have been 1596 cases considered/received since the Scheme
began. 160 of these cases have resulted in successful claims. To
date compensation payments amounting to £8.257m have been
paid to claimants. The successful cases include 16 cases which were
identified during the main retrospection exercise, plus 4 cases
(identified to date) following the cataract retrospection exercise.
Information about CSRLD is available to interested parties via
the internet. The scheme’s website (www.csrld.org.uk) is designed
primarily to provide relevant guidance to potential claimants (and
others acting on their behalf) but also provides contact information
for those seeking further information. Over the past year the site
has continued to receive many regular visits, and has provided the
means to initiate a number of claims.
For further information please contact:-
The Compensation Scheme Executive Secretariat
Cumbria CA20 1PG
Tel 019467 74716
Each Compensation Scheme Management Board (CSMB) produces a progress report , examples from the NDA Sites and MoD/AWE Boards are attached below.
The updated Specified
Companies summaries & schedules are also attached.
• NDA Sites